Thromboxane A2 receptor antagonist SQ29548 suppresses the LPS-induced release of inflammatory cytokines in BV2 microglia cells via suppressing MAPK and NF-κB signaling pathways
Aijuan Yan(Shanghai Jiao Tong University), Yi Fu(Shanghai Jiao Tong University)
Cited by 21
Related Papers
A Randomized, Double‐blind, Placebo‐controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese Patients
|Pain Practice|2015|31
Thromboxane A2 receptor antagonist SQ29548 attenuates SH‑SY5Y neuroblastoma cell impairments induced by oxidative stress
|International Journal of Molecular Medicine|2018|9